Korean J Lab Med.  2006 Feb;26(1):52-57. 10.3343/kjlm.2006.26.1.52.

Evaluation of Indigenously Manufactured Immunochromatographic Assay Systems for Rapid Detection of Hepatitis B Surface Antigen and Antibody

• Cha YJ
• Yang JS
• Chae SL

• KMID: 2143198
• DOI: http://doi.org/10.3343/kjlm.2006.26.1.52

Abstract

BACKGROUND: We evaluated three indigenously produced immunochromatography (ICA) kits for the rapid detection of hepatitis B surface antigen (HBsAg) and antibody to HBsAg (anti-HBs) by comparing them with a microparticle enzyme immunoassay (MEIA).
METHODS
HBsAg and anti-HBs were tested by the ICA kits manufactured by three domestic companies, SD HBsAg and Anti-HBs (Standard Diagnostics, Inc., Yongin, Korea); Asan Easy Test(R) HBsAg and Anti-HBs (Asan Pharm Co., Ltd., Whasung, Korea); and GENEDIA(R) HBsAg Rapid Device and Anti-HBs Rapid Device (Green Cross MS, Inc., Yongin, Korea).
RESULTS
Results by ICA agreed completely with those of MEIA in all the 20 HBsAg-negative sera and in all the anti-HBs-negative sera except one sample. Among the 20 HBsAg-positive sera by MEIA, 17 were positive by ICA using Green Cross MS, 16 using Asan Pharm Co., and 13 using SD and reverse passive hemagglutination. Among the 20 anti-HBs-positive sera by MEIA, 19 were positive by ICA using Green Cross MS and Asan Pharm Co., 17 using SD, and 18 by passive hemagglutination. Elapsed time for the control and test line to be visualized in ICA might be longer and the color of the lines lighter when using SD than Green Cross MS or Asan Pharm Co.
CONCLUSIONS
Three indigenously produced ICA kits are as sensitive as MEIA for the detection of anti-HBs, but are less sensitive than MEIA for HBsAg. The ICA kits for the rapid detection of HBsAg might be recommended for a limited use in the clinical laboratory.

Keyword

Immunochromatography (ICA); HBsAg; anti-HBs; MEIA; Rapid detection

MeSH Terms

Chungcheongnam-do
Gyeonggi-do
Hemagglutination
Hepatitis B Surface Antigens*
Hepatitis B*
Hepatitis*
Immunochromatography*
Immunoenzyme Techniques
Hepatitis B Surface Antigens

Reference

References

1. Kashiwagi S, Hayashi J, Noguchi A, Nakashima K, Kishihara Y. Evaluation of immunochromatography assay technique for detection of hepatitis B surface antigen. Kansenshogaku Zasshi. 1994; 68:916–22.

2. Sato K, Ichiyama S, Iinuma Y, Nada T, Shimokata K, Nakashima N. Evaluation of immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody, Dainascreen HBsAg and Dainascreen Ausab. J Clin Microbiol. 1996; 34:1420–2.

3. Vaughn DW, Nisalak A, Kalayanarooj S, Solomon T, Dung NM, Cuzzubbo A, et al. Evaluation of a rapid immunochromatographic test for diagnosis of dengue virus infection. J Clin Microbiol. 1998; 36:234–8.

4. Kashiwagi S, Hayashi J, Kakuda K, Yamaji K, Ueno K, Tani Y. Evaluation of immunochromatography assay technique for detection of antibody to hepatitis B surface antigen (HBsAg). Kansenshogaku Zasshi. 1995; 69:297–302.

5. Laitinen MP, Vuento M. Immunochromatographic assay for quantitation of milk progesterone. Acta Chem Scand. 1996; 50:141–5.

6. Habib MP, Schifman RB, Shon BY, Fiastro JF, Campbell SC. Evaluation of whole blood theophylline enzyme immunochromatography assay. Chest. 1987; 92:129–31.

7. Raj AA, Subramaniam T, Raghuraman S, Abraham P. Evaluation of an indigenously manufactured rapid immunochromatographic test for detection of HBsAg. Indian J Pathol Microbiol. 2001; 44:413–4.

8. Lau DT, Ma H, Lemon SM, Doo E, Ghany MG, Miskovsky E, et al. A rapid immunochromatographic assay for hepatitis B virus screening. J Viral Hepat. 2003; 10:331–4.

9. Cha YJ, Kum DG, Kim SW, Kim TY, Kim JR, Kim HS, et al. Annual report on external quality assessment in immunoserology in Korea (2001). J Lab Med Quality Assurance. 2002; 24:27–38.

10. Cha YJ, Kum DG, Kim SW, Kim TY, Kim JR, Kim HS, et al. Annual report on external quality assessment in immunoserology in Korea (2002). J Lab Med Quality Assurance. 2003; 25:51–71.

11. Cha YJ, Kwon SY, Kum DG, Kim SW, Kim TY, Kim JR, et al. Annual report on external quality assessment in immunoserology in Korea (2003). J Lab Med Quality Assurance. 2004; 26:47–69.

12. Cha YJ, Kwon SY, Kum DG, Kim SW, Kim TY, Kim JR, et al. Annual report on external quality assessment in immunoserology in Korea (2004). J Lab Med Quality Assurance. 2005; 27:37–57.

13. Moerman B, Moons V, Sommer H, Schmitt Y, Stetter M. Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clin Lab. 2004; 50:159–62.

14. Saito T, Shinzawa H, Uchida T, Kawamata O, Honma S, Watanabe H, et al. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol. 1999; 58:325–31.

15. Sakugawa H, Kobashigawa K, Nakayoshi T, Yamashiro T, Maeshiro T, Tomimori K, et al. Monitoring low level hepatitis B virus by a newly developed sensitive test. Hepatol Res. 2003; 26:281–6.

16. Allain JP. Occult hepatitis B virus infection. Transfus Clin Biol. 2004; 11:18–25.

17. Whang DH, Um T. Comparison of immunochromatography assays and quantitative immunoassays for detecting HBsAg and anti-HBs. Korean J Lab Med. 2005; 25:186–91.

18. Zaaijer HL, Vrielink H, Koot M. Early detection of hepatitis B surface antigen and detection of HBsAg mutants: a comparison of five assays. Vox Sang. 2001; 81:219–21.

19. Dreier J, Kroger M, Diekmann J, Gotting C, Kleesiek K. Low-level viraemia of hepatitis B virus in an anti-HBc- and anti-HBs-positive blood donor. Transfus Med. 2004; 14:97–103.

20. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004; 86:83–91.